+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Radiation therapy for the treatment of locally advanced and metastatic prostate cancer



Radiation therapy for the treatment of locally advanced and metastatic prostate cancer



Hematology/Oncology Clinics of North America 15(3): 423-443



Radiation therapy for locally advanced PCa continues to evolve. A current treatment recommendation for nonmetastatic, high-risk disease includes AS combined with RT. The precise duration and sequencing of AS has not been established but most frequently includes treatment in the neoadjuvant, concomitant and, occasionally, adjuvant periods. As technology allows higher doses without significant increases in morbidity and as clinical data provide proof of a radiation dose response, RT doses continue to escalate. The goal of therapy for metastatic disease continues to focus on the relief of pain and the improvement in quality of life. Multiple studies document the significant role RT plays in achieving these goals. Focal RT and systemic radioisotopes have become the mainstay of management in this patient group and the development of newer isotopes that cause less marrow toxicity will improve the therapeutic ratio and provide an opportunity for their use with systemic chemotherapy. As molecular and genomic technologies advance, directed targeting of critical cellular radiation-response pathways hold the promise of improved radiation response and individualized, tailored therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 035603293

Download citation: RISBibTeXText

PMID: 11525289

DOI: 10.1016/s0889-8588(05)70224-0


Related references

Long-term outcome for patients with locally advanced non-metastatic prostate cancer treated with adjuvant hormones and radiation therapy versus radiation therapy alone Subset analysis of RTOG 85-31 and 86-10. International Journal of Radiation Oncology Biology Physics 45(3 SUPPL ): 220-221, 1999

Treatment of locally advanced prostate cancer with radiation therapy. Urology 33(5 Suppl.): 37-41, 1989

Locally advanced prostate cancer Results of radical prostatectomy versus combined radiation treatment with neoadjuvant hormonal therapy, Pd-103 seed implantation and 3-D conformal radiation therapy. International Journal of Radiation Oncology Biology Physics 48(3 Suppl.): 311, 2000

Is adjuvant long-term hormone use necessary when high dose 3D conformal radiation is used in the treatment of locally advanced non-metastatic prostate cancer. International Journal of Radiation Oncology Biology Physics 51(3 Suppl. 1): 285, 2001

Hormonal Therapy and Radiation Therapy in the Treatment of Locally Advanced Prostate Cancer. Molecular Urology 3(3): 227-230, 2000

An overview of the First International Consensus Workshop on Radiation Therapy in the Treatment of Metastatic and Locally Advanced Cancer. International Journal of Radiation Oncology, Biology, Physics 23(1): 201, 1992

Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer. Bju International 100 Suppl 2: 44-47, 2007

Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer. Clinical Oncology ) 28(6): 376-385, 2017

A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer. Clinical Colorectal Cancer 9(2): 119-125, 2010

Validation of the quality of life-radiation therapy instrument in patients receiving definitive radiation therapy for locally advanced prostate cancer. International Journal of Radiation Oncology Biology Physics 36(1 SUPPL ): 269, 1996

Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer. Der Urologe. Ausg. a 49(2): 211-215, 2011

Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer. Bju International 114(4): 608-616, 2014

Androgen deprivation therapy in locally advanced and metastatic prostate cancer. Minerva Urologica E Nefrologica 58(3): 119-126, 2006

Should Treatment with Radiation and Androgen Deprivation Therapy be Considered the 'Gold Standard' for Men with Unfavourable Intermediate- to High-risk and Locally Advanced Prostate Cancer?. Clinical Oncology ) 28(8): 475-478, 2016

Radiation therapy for locally advanced prostate cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 5: 424-426, 2012